What is Shantel?
Established in 1990 and headquartered in Southern California, Shantel operates as a comprehensive provider of cosmeticeuticals, cosmetics, and personal care products. The company distinguishes itself through a dual-focus model: providing wholesale distribution to domestic and international markets while offering specialized custom manufacturing and private label services. By enabling clients to develop bespoke skin care lines, Shantel has cemented its reputation within the medical and dermatological sectors. Their portfolio includes the RxFace Professional Clinical PrePost Treatment Skin Care Line, which highlights the firm's commitment to evidence-based product development and clinical efficacy.
How much funding has Shantel raised?
Shantel has raised a total of $34K across 1 funding round:
Debt
$34K
Debt (2021): $34K with participation from PPP
Key Investors in Shantel
PPP
Public-Private Partnership
What's next for Shantel?
The recent influx of capital positions Shantel to accelerate its operational scaling and enhance its manufacturing capabilities. Given the company's established history and its focus on the high-barrier-to-entry medical skin care market, this funding will likely be directed toward expanding production capacity to meet rising global demand for private label solutions. Furthermore, the firm is well-positioned to leverage its deep expertise in dermatological formulations to introduce new, innovative product lines, thereby strengthening its competitive moat against emerging direct-to-consumer beauty brands. As the company transitions through this growth phase, the focus will remain on maintaining the rigorous quality standards that have defined its three-decade tenure in the industry.
See full Shantel company page
